IP Verse

Safe And Effective Method Of Treating Ulcerative Colitis With Anti Il12/Il23 Antibody - EP3883606

PATENT ANALYSIS

Patent Details

Grant Date
Oct 4, 2023
Company
JANSSEN BIOTECH, INC.
Oppositions

ACCORD HEALTHCARE LTD

BIOCON BIOLOGICS LIMITED

CAMULON LTD

KARO IP PATENTANWALTE KAHLHOFER ROSSLER KREUELS PARTG MBB

SAMSUNG BIOEPIS NL B.V.

More patents of Janssen Biotech, Inc.

EP3883606

EP2970980

EP3827845

Want to monitor this patent?

Feel free to send us a message here and we will get back to you